JEFFREY MORRIS to Middle Aged
This is a "connection" page, showing publications JEFFREY MORRIS has written about Middle Aged.
Connection Strength
0.157
-
I-CLIP: improved stratification of advanced hepatocellular carcinoma patients by integrating plasma IGF-1 into CLIP score. Oncology. 2011; 80(5-6):373-81.
Score: 0.015
-
V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials. Cancer. 2011 Jun 01; 117(11):2478-88.
Score: 0.015
-
The accuracy of endoscopic ultrasound for restaging esophageal carcinoma after chemoradiation therapy. Cancer. 2004 Sep 01; 101(5):940-7.
Score: 0.009
-
Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma. Gastroenterology. 2015 Jul; 149(1):119-29.
Score: 0.005
-
Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma. Cell Death Dis. 2014 Dec 04; 5:e1559.
Score: 0.005
-
Impact of molecular alterations and targeted therapy in appendiceal adenocarcinomas. Oncologist. 2013; 18(12):1270-7.
Score: 0.004
-
The association of alternate VEGF ligands with resistance to anti-VEGF therapy in metastatic colorectal cancer. PLoS One. 2013; 8(10):e77117.
Score: 0.004
-
Geographic disparities in mammography capacity in the South: a longitudinal assessment of supply and demand. Health Serv Res. 2014 Feb; 49(1):171-85.
Score: 0.004
-
Efficacy of bevacizumab plus erlotinib for advanced hepatocellular carcinoma and predictors of outcome: final results of a phase II trial. Oncology. 2012; 82(2):67-74.
Score: 0.004
-
Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial. Cancer Chemother Pharmacol. 2011 Dec; 68(6):1431-8.
Score: 0.004
-
Phase II study of short-course capecitabine plus oxaliplatin (XELOX) followed by maintenance capecitabine in advanced colorectal cancer: XelQuali study. Cancer Chemother Pharmacol. 2011 May; 67(5):1111-7.
Score: 0.004
-
Profiling lipoxygenase metabolism in specific steps of colorectal tumorigenesis. Cancer Prev Res (Phila). 2010 Jul; 3(7):829-38.
Score: 0.004
-
Preoperative downstaging chemoradiation with concurrent irinotecan and capecitabine in MRI-defined locally advanced rectal cancer: a phase I trial (NWCOG-2). Br J Cancer. 2009 Sep 15; 101(6):924-34.
Score: 0.003
-
Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA. 2009 Jun 24; 301(24):2553-62.
Score: 0.003
-
Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma. Arch Surg. 2009 Mar; 144(3):216-21.
Score: 0.003
-
15-LOX-1 transcription suppression through the NuRD complex in colon cancer cells. Oncogene. 2009 Mar 26; 28(12):1496-505.
Score: 0.003
-
Exploring the association between elevated body mass index and Barrett's esophagus: a systematic review and meta-analysis. Ann Thorac Surg. 2009 Feb; 87(2):655-62.
Score: 0.003
-
DNA repair gene polymorphisms and risk of pancreatic cancer. Clin Cancer Res. 2009 Jan 15; 15(2):740-6.
Score: 0.003
-
Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma. J Clin Oncol. 2009 Feb 20; 27(6):843-50.
Score: 0.003
-
Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma. Cancer. 2008 Oct 15; 113(8):2038-45.
Score: 0.003
-
Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma. Clin Cancer Res. 2008 May 01; 14(9):2560-9.
Score: 0.003
-
Prevalence of colorectal neoplasm among patients with newly diagnosed coronary artery disease. JAMA. 2007 Sep 26; 298(12):1412-9.
Score: 0.003
-
Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma. Cancer. 2007 Sep 01; 110(5):1059-67.
Score: 0.003
-
Clinical stage after preoperative chemoradiation is a better predictor of patient outcome than the baseline stage for localized gastric cancer. Cancer. 2007 Sep 01; 110(5):989-95.
Score: 0.003
-
Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia. Cancer. 2007 Feb 15; 109(4):668-74.
Score: 0.003
-
Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2006 Nov 01; 66(3):762-71.
Score: 0.003
-
Surgical pathology stage by American Joint Commission on Cancer criteria predicts patient survival after preoperative chemoradiation for localized gastric carcinoma. Cancer. 2006 Oct 01; 107(7):1475-82.
Score: 0.003
-
Retrospective study of capecitabine and celecoxib in metastatic colorectal cancer: potential benefits and COX-2 as the common mediator in pain, toxicities and survival? Am J Clin Oncol. 2006 Jun; 29(3):232-9.
Score: 0.003
-
Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma. Cancer. 2005 Oct 15; 104(8):1620-6.
Score: 0.003
-
Discrete serum protein signatures discriminate between human retrovirus-associated hematologic and neurologic disease. Leukemia. 2005 Jul; 19(7):1229-38.
Score: 0.003
-
Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation. Cancer. 2005 Apr 01; 103(7):1347-55.
Score: 0.002
-
BRAF mutations in aberrant crypt foci and hyperplastic polyposis. Am J Pathol. 2005 Apr; 166(4):1069-75.
Score: 0.002
-
Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol. 2005 Feb; 16(2 Pt 1):215-25.
Score: 0.002
-
Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma. J Clin Oncol. 2004 Jul 15; 22(14):2774-80.
Score: 0.002
-
Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction. Cancer. 2004 Jun 01; 100(11):2347-54.
Score: 0.002
-
Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients. Cancer Epidemiol Biomarkers Prev. 2004 Jun; 13(6):920-7.
Score: 0.002
-
Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol. 2003 Nov; 10(9):1059-69.
Score: 0.002
-
Cutaneous angiosarcoma of the scalp: a multidisciplinary approach. Cancer. 2003 Oct 15; 98(8):1716-26.
Score: 0.002
-
Portal vein embolization with polyvinyl alcohol particles and coils in preparation for major liver resection for hepatobiliary malignancy: safety and effectiveness--study in 26 patients. Radiology. 2003 Apr; 227(1):251-60.
Score: 0.002
-
Effect of celecoxib on capecitabine-induced hand-foot syndrome and antitumor activity. Oncology (Williston Park). 2002 Dec; 16(12 Suppl No 14):31-7.
Score: 0.002
-
Concordant CpG island methylation in hyperplastic polyposis. Am J Pathol. 2002 Feb; 160(2):529-36.
Score: 0.002
-
CpG island methylation in colorectal adenomas. Am J Pathol. 2001 Sep; 159(3):1129-35.
Score: 0.002